Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Saverglass and some of the Australian cans business serve the premium and ultrapremium liquor and wine end-markets. We think revenue is likely to grow above nominal GDP, at about mid-single digits due ...

The Australian and New Zealand general insurance market is dominated by a handful of large players. Insurance Australia Group’s AUD 16 billion in gross written premiums makes it the market leader.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

The company, which is best known globally for its Penfolds brand, hopes the creation of a separate luxury division will help lift performance. On Thursday, it said it had completed the integration of ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Junior explorers are beefing up drilling efforts in the Pilbara as record gold prices reignite search for the next Hemi.

The euro rose 0.5% on Tuesday and was last steady while sterling rose about 0.7% and hovered at $1.2441 early in the Asia ...